Skip to main content



ViaLogy of Pasadena, Calif, a spinoff of ViaSpace Technologies, a technology commercialization company developed by the NASA/Caltech Jet Propulsion Laboratory, this week announced the launch of a microarray analysis service targeting large-scale users of microarrays. ViaLogy will launch services based on its quantum resonance interferometry (QRI) technology, a proprietary method that it says can amplify signals previously garbled by background interference.

The company will accept data files from existing microarray instrumentation and databases and reprocess it using its technology in a service available online on a pay-per-use basis, the company said in a statement. The online service will become available in December.

Results should be available within 24 hours, the company said.

The ViaLogy technology, based on concepts gleaned from aerospace research, allows the amplification of signals to enable the detection and quantification of hybridization events that other technologies might not perceive due to background noise.

ViaLogy’s microarray service is pre-calibrated and selectable for several different types of Affymetrix GeneChip technology and the company is adding capabilities for formats on glass slides.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.